Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,580,314
-
Share change
-
-7,924,641
-
Total reported value
-
$6,283,131
-
Put/Call ratio
-
10%
-
Price per share
-
$0.50
-
Number of holders
-
69
-
Value change
-
-$3,158,727
-
Number of buys
-
24
-
Number of sells
-
25
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q3 2019
As of 30 Sep 2019,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,580,314 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PRIVATE CAPITAL MANAGEMENT LLC, Western Wealth Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, COURIER CAPITAL LLC, Cypress Capital Management LLC (WY), Carnick & Kubik Group, LLC, and RAYMOND JAMES & ASSOCIATES.
This page lists
69
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.